JP2025509627A - マイコプラズマ・シノビエ生ワクチン - Google Patents

マイコプラズマ・シノビエ生ワクチン Download PDF

Info

Publication number
JP2025509627A
JP2025509627A JP2024554890A JP2024554890A JP2025509627A JP 2025509627 A JP2025509627 A JP 2025509627A JP 2024554890 A JP2024554890 A JP 2024554890A JP 2024554890 A JP2024554890 A JP 2024554890A JP 2025509627 A JP2025509627 A JP 2025509627A
Authority
JP
Japan
Prior art keywords
mycoplasma synoviae
vaccine
bird
composition
mycoplasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024554890A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025509627A5 (https=
Inventor
ファーガソン-ノエル,ナオラ,エム.
Original Assignee
ユニバーシティ オブ ジョージア リサーチ ファンデーション,インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニバーシティ オブ ジョージア リサーチ ファンデーション,インコーポレーテッド filed Critical ユニバーシティ オブ ジョージア リサーチ ファンデーション,インコーポレーテッド
Publication of JP2025509627A publication Critical patent/JP2025509627A/ja
Publication of JP2025509627A5 publication Critical patent/JP2025509627A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2024554890A 2022-03-14 2023-03-13 マイコプラズマ・シノビエ生ワクチン Pending JP2025509627A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263319532P 2022-03-14 2022-03-14
US63/319,532 2022-03-14
PCT/US2023/015103 WO2023177620A1 (en) 2022-03-14 2023-03-13 Live mycoplasma synoviae vaccine

Publications (2)

Publication Number Publication Date
JP2025509627A true JP2025509627A (ja) 2025-04-11
JP2025509627A5 JP2025509627A5 (https=) 2026-03-19

Family

ID=88024180

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024554890A Pending JP2025509627A (ja) 2022-03-14 2023-03-13 マイコプラズマ・シノビエ生ワクチン

Country Status (8)

Country Link
US (1) US20250186512A1 (https=)
EP (1) EP4493202A1 (https=)
JP (1) JP2025509627A (https=)
CN (1) CN118891358A (https=)
AR (1) AR128777A1 (https=)
AU (1) AU2023235062A1 (https=)
MX (1) MX2024011062A (https=)
WO (1) WO2023177620A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA9710606B (en) * 1996-12-05 1998-06-12 Akzo Nobel Nv Non-virulent Mycoplasma synoviae vaccine thereof.
EP3391903B1 (en) * 2017-04-21 2022-02-23 The Pirbright Institute Recombinant gallid herpesvirus 3 vaccines encoding heterologous avian pathogen antigens
CN112779193B (zh) * 2021-02-24 2022-09-27 福建省农业科学院畜牧兽医研究所 一株滑液囊支原体强毒株及其应用

Also Published As

Publication number Publication date
MX2024011062A (es) 2024-09-23
US20250186512A1 (en) 2025-06-12
WO2023177620A9 (en) 2024-05-10
CN118891358A (zh) 2024-11-01
EP4493202A1 (en) 2025-01-22
AU2023235062A1 (en) 2024-09-19
WO2023177620A1 (en) 2023-09-21
AR128777A1 (es) 2024-06-12

Similar Documents

Publication Publication Date Title
US7879336B2 (en) Vaccines and methods to treat canine influenza
JP5789897B2 (ja) マイコプラズマ・ボビス ワクチン
JP2025510684A (ja) マイコプラズマ・ガリセプティカム生ワクチン
US20170274065A1 (en) Attenuated bovine coronavirus and related vaccines
JP2013223511A6 (ja) マイコプラズマ・ボビス ワクチン
JP2011500093A6 (ja) マイコプラズマ・ボビス ワクチン
US11814653B2 (en) Attenuated isolate of infectious bronchitis virus strain DMV1639
US8668912B2 (en) Mycoplasma gallisepticum formulation
US7217420B2 (en) Mycoplasma gallisepticum formulation
JP3945885B2 (ja) 非毒性Mycoplasma synoviaeとそのワクチン
JP2025509627A (ja) マイコプラズマ・シノビエ生ワクチン
RU2844767C1 (ru) Аттенуированный изолят штамма dmv1639 вируса инфекционного бронхита
US9764017B2 (en) Potomac horse fever isolates

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20241106

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20241106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260311

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260311